tiprankstipranks
Advertisement
Advertisement
Akari Therapeutics announces strategic partnership with WuXi XDC
PremiumThe FlyAkari Therapeutics announces strategic partnership with WuXi XDC
1M ago
Akari Therapeutics target adjusted to $27 from $1.60 at H.C. Wainwright
Premium
The Fly
Akari Therapeutics target adjusted to $27 from $1.60 at H.C. Wainwright
1M ago
Akari Therapeutics trading halted, news pending
Premium
The Fly
Akari Therapeutics trading halted, news pending
1M ago
Akari Therapeutics appoints Gokhale to its Scientific Advisory Board
PremiumThe FlyAkari Therapeutics appoints Gokhale to its Scientific Advisory Board
2M ago
Akari Therapeutics appoints Olga Anczukow to SAB
Premium
The Fly
Akari Therapeutics appoints Olga Anczukow to SAB
2M ago
Akari Therapeutics files patent covering AKTX-102
Premium
The Fly
Akari Therapeutics files patent covering AKTX-102
3M ago
Akari Therapeutics Approves Key Resolutions at Meeting
PremiumCompany AnnouncementsAkari Therapeutics Approves Key Resolutions at Meeting
5M ago
Akari Therapeutics announces $5M financing
Premium
The Fly
Akari Therapeutics announces $5M financing
5M ago
Akari Therapeutics announces preclinical data on AKTX-101
Premium
The Fly
Akari Therapeutics announces preclinical data on AKTX-101
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100